<?xml version='1.0' encoding='utf8'?>
<text id="AMALGUM_academic_glycation" title="Wnt Glycation Inhibits Canonical Signaling" shortTitle="glycation" author="Zhennan Ye, Sonnhild Mittag, Martin Schmidt, Andreas Simm, Rüdiger Horstkorte, Otmar Huber" type="academic" dateCollected="2019-11-03" sourceURL="https://www.mdpi.com/2073-4409/8/11/1320/htm" speakerList="none" speakerCount="0">
<head>
<s type="frag">
1.	LS	1.
Introduction	NN	introduction
</s>
</head>
<p>
<s type="decl">
Aging-associated	JJ	Aging-associated
disabilities	NNS	disability
are	VBP	be
generated	VBN	generate
by	IN	by
an	DT	a
accumulation	NN	accumulation
of	IN	of
randomly	RB	randomly
occurring	VBG	occur
molecular	JJ	molecular
damages	NNS	damage
during	IN	during
life	NN	life
time	NN	time
,	,	,
which	WDT	which
affect	VBP	affect
the	DT	the
organism	NN	organism
at	IN	at
multiple	JJ	multiple
levels	NNS	level
such	JJ	such
as	IN	as
metabolism	NN	metabolism
,	,	,
immune	JJ	immune
response	NN	response
,	,	,
repair	NN	repair
,	,	,
and	CC	and
regeneration	NN	regeneration
as	RB	as
well	RB	well
as	IN	as
altered	VBN	alter
inter-	JJ	inter-
and	CC	and
intracellular	JJ	intracellular
communication	NN	communication
.	.	.
</s>
<s type="decl">
Typical	JJ	typical
alterations	NNS	alteration
detectable	JJ	detectable
in	IN	in
aged	JJ	aged
tissues	NNS	tissue
are	VBP	be
increased	VBN	increase
concentrations	NNS	concentration
of	IN	of
reactive	JJ	reactive
oxygen	NN	oxygen
species	NNS	species
(	-LRB-	(
ROS	NNS	ROS
)	-RRB-	)
and	CC	and
concomitant	JJ	concomitant
increased	VBN	increase
DNA-damage	NN	dna-damage
,	,	,
lipid	NN	lipid
and	CC	and
protein	NN	protein
oxidation	NN	oxidation
.	.	.
</s>
<s type="decl">
Often	RB	often
this	DT	this
is	VBZ	be
accompanied	VBN	accompany
by	IN	by
accumulation	NN	accumulation
of	IN	of
insoluble	JJ	insoluble
protein	NN	protein
aggregates	NNS	aggregate
(	-LRB-	(
lipofuscin	NN	lipofuscin
)	-RRB-	)
at	IN	at
least	JJS	least
partially	RB	partially
as	IN	as
a	DT	a
consequence	NN	consequence
of	IN	of
impaired	VBN	impair
proteasome	NN	proteasome
function	NN	function
.	.	.
</s>
<s type="decl">
In	IN	in
addition	NN	addition
,	,	,
glycation	NN	glycation
was	VBD	be
reported	VBN	report
to	TO	to
contribute	VB	contribute
to	IN	to
limited	JJ	limited
degradation	NN	degradation
and	CC	and
function	NN	function
of	IN	of
proteins	NNS	protein
.	.	.
</s>
<s type="decl">
Glycation	NNP	Glycation
represents	VBZ	represent
an	DT	a
important	JJ	important
posttranslational	JJ	posttranslational
modification	NN	modification
that	WDT	that
significantly	RB	significantly
increases	VBZ	increase
during	IN	during
aging	NN	aging
and	CC	and
results	VBZ	result
in	IN	in
the	DT	the
formation	NN	formation
of	IN	of
advanced	JJ	advanced
glycation	NN	glycation
end	NN	end
products	NNS	product
(	-LRB-	(
AGEs	NNS	age
)	-RRB-	)
.	.	.
</s>
</p>
<p>
<s type="decl">
AGEs	NNS	age
are	VBP	be
generated	VBN	generate
by	IN	by
an	DT	a
initial	JJ	initial
non-enzymatic	JJ	non-enzymatic
reaction	NN	reaction
of	IN	of
amino	JJ	amino
groups	NNS	group
with	IN	with
reactive	JJ	reactive
carbonyl	NN	carbonyl
groups	NNS	group
of	IN	of
monosaccharides	NNS	monosaccharide
known	VBN	know
as	IN	as
the	DT	the
Maillard	NNP	Maillard
reaction	NN	reaction
,	,	,
thereby	RB	thereby
forming	VBG	form
Schiff-base	NNP	Schiff-base
adducts	NNS	adduct
.	.	.
</s>
<s type="decl">
These	DT	this
adducts	NNS	adduct
are	VBP	be
subsequently	RB	subsequently
rearranged	VBN	rearrange
to	IN	to
so-called	JJ	so-called
Amadori	NNP	Amadori
products	NNS	product
which	WDT	which
undergo	VBP	undergo
further	JJ	further
oxidation	NN	oxidation
and	CC	and
dehydration	NN	dehydration
reactions	NNS	reaction
leading	VBG	lead
to	IN	to
a	DT	a
large	JJ	large
group	NN	group
of	IN	of
heterogeneous	JJ	heterogeneous
products	NNS	product
.	.	.
</s>
<s type="decl">
Up	RB	up
to	IN	to
the	DT	the
stage	NN	stage
of	IN	of
the	DT	the
Amadori	NNP	Amadori
products	NNS	product
,	,	,
adducts	NNS	adduct
are	VBP	be
basically	RB	basically
reversible	JJ	reversible
.	.	.
</s>
<s type="decl">
Preferentially	RB	preferentially
lysine	NN	lysine
residues	NNS	residue
,	,	,
but	CC	but
also	RB	also
other	JJ	other
amino	NN	amino
acids	NNS	acid
including	VBG	include
arginine	NN	arginine
,	,	,
histidine	NN	histidine
,	,	,
tryptophan	NN	tryptophan
,	,	,
or	CC	or
cysteine	NN	cysteine
,	,	,
are	VBP	be
modified	VBN	modify
by	IN	by
glycation	NN	glycation
.	.	.
</s>
<s type="decl">
The	DT	the
most	RBS	most
prominent	JJ	prominent
and	CC	and
well-known	JJ	well-known
AGEs	NNS	age
identified	VBN	identify
in	IN	in
cells	NNS	cell
and	CC	and
tissues	NNS	tissue
are	VBP	be
carboxymethyllysine	RB	carboxymethyllysine
(	-LRB-	(
CML	NNP	CML
)	-RRB-	)
,	,	,
carboxyethyllysine	NN	carboxyethyllysine
(	-LRB-	(
CEL	NNP	CEL
)	-RRB-	)
,	,	,
pentosidine	NN	pentosidine
,	,	,
and	CC	and
desoxyglucosone	NN	desoxyglucosone
.	.	.
</s>
<s type="decl">
Physiologically	RB	physiologically
,	,	,
these	DT	this
AGEs	NNS	age
are	VBP	be
formed	VBN	form
in	IN	in
response	NN	response
to	IN	to
so-called	JJ	so-called
“	``	''
dicarbonyl	NN	dicarbonyl
stress	NN	stress
”	''	''
as	IN	as
given	VBN	give
under	IN	under
conditions	NNS	condition
of	IN	of
hyperglycemia	NN	hyperglycemia
or	CC	or
in	IN	in
the	DT	the
presence	NN	presence
of	IN	of
highly	RB	highly
reactive	JJ	reactive
α-dicarbonyls	NNS	h-dicarbonyl
(	-LRB-	(
α-DCs	FW	C-DCs
)	-RRB-	)
such	JJ	such
as	IN	as
glyoxal	NN	glyoxal
(	-LRB-	(
GO	NNP	GO
)	-RRB-	)
,	,	,
methylglyoxal	RB	methylglyoxal
(	-LRB-	(
MGO	NNP	MGO
)	-RRB-	)
or	CC	or
3-deoxyglucosone	NN	3-deoxyglucosone
.	.	.
</s>
<s type="decl">
These	DT	this
α-DCs	NNS	X-DC
are	VBP	be
inevitable	JJ	inevitable
byproducts	NNS	byproduct
of	IN	of
anaerobic	JJ	anaerobic
glycolysis	NN	glycolysis
and	CC	and
lipid	NN	lipid
peroxidation	NN	peroxidation
and	CC	and
in	IN	in
consequence	NN	consequence
,	,	,
induce	VBP	induce
the	DT	the
formation	NN	formation
of	IN	of
highly	RB	highly
stable	JJ	stable
AGEs	NNS	age
which	WDT	which
crosslink	VBP	crossle
proteins	NNS	protein
and	CC	and
lead	VBP	lead
to	IN	to
protease-resistant	JJ	protease-resistant
protein	NN	protein
aggregates	NNS	aggregate
.	.	.
</s>
<s type="decl">
In	IN	in
this	DT	this
context	NN	context
,	,	,
glycation-induced	JJ	glycation-induced
modifications	NNS	modification
of	IN	of
extracellular	JJ	extracellular
matrix	NN	matrix
proteins	NNS	protein
resulting	VBG	result
in	IN	in
intermolecular	JJ	intermolecular
crosslinks	NNS	crosslink
lead	VBP	lead
to	IN	to
increased	VBN	increase
stiffness	NN	stiffness
of	IN	of
tissues	NNS	tissue
and	CC	and
vessels	NNS	vessel
and	CC	and
affect	VBP	affect
cell	NN	cell
migration	NN	migration
.	.	.
</s>
<s type="decl">
Furthermore	RB	furthermore
,	,	,
there	EX	there
is	VBZ	be
clear	JJ	clear
evidence	NN	evidence
that	IN	that
glycation	NN	glycation
and	CC	and
AGEs	NNS	age
lead	VBP	lead
to	IN	to
mitochondrial	JJ	mitochondrial
dysfunction	NN	dysfunction
and	CC	and
impaired	VBN	impair
immune	JJ	immune
responses	NNS	response
.	.	.
</s>
<s type="decl">
Glycation	NN	glycation
of	IN	of
growth	NN	growth
factors	NNS	factor
such	JJ	such
as	IN	as
platelet-derived	NN	platelet-derived
growth	NN	growth
factor	NN	factor
(	-LRB-	(
PDGF	NNP	PDGF
)	-RRB-	)
and	CC	and
insulin	NN	insulin
,	,	,
as	RB	as
well	RB	well
as	IN	as
receptors	NNS	receptor
such	JJ	such
as	IN	as
nerve	NN	nerve
growth	NN	growth
factor	NN	factor
(	-LRB-	(
NGF)-receptor	NNP	NGF)-receptor
,	,	,
were	VBD	be
reported	VBN	report
to	TO	to
affect	VB	affect
signaling	NN	signaling
functions	NNS	function
.	.	.
</s>
</p>
<p>
<s type="decl">
In	IN	in
addition	NN	addition
,	,	,
AGE	NN	AGE
modification	NN	modification
itself	PRP	itself
can	MD	can
induce	VB	induce
signaling	NN	signaling
mainly	RB	mainly
through	IN	through
the	DT	the
receptor	NN	receptor
for	IN	for
advanced	JJ	advanced
glycation	NN	glycation
end	NN	end
products	NNS	product
(	-LRB-	(
RAGE	NNP	RAGE
)	-RRB-	)
,	,	,
a	DT	a
multi-ligand	JJ	multi-ligand
transmembrane	NN	transmembrane
receptor	NN	receptor
containing	VBG	contain
immunoglobulin	NN	immunoglobulin
domains	NNS	domain
.	.	.
</s>
<s type="decl">
RAGE-induced	VBN	rage-induce
signaling	NN	signaling
contributes	VBZ	contribute
to	IN	to
aging-related	JJ	aging-related
inflammation	NN	inflammation
and	CC	and
metabolic	JJ	metabolic
diseases	NNS	disease
by	IN	by
modulation	NN	modulation
of	IN	of
multiple	JJ	multiple
pathways	NNS	pathway
including	VBG	include
phosphoinositide	NN	phosphoinositide
3-kinase	NN	3-kinase
(	-LRB-	(
PI3K	NNP	PI3K
)	-RRB-	)
,	,	,
Erk1/2	NNP	Erk1/2
and	CC	and
Wnt	NNP	Wnt
signaling	NN	signaling
.	.	.
</s>
<s type="decl">
However	RB	however
,	,	,
the	DT	the
outcome	NN	outcome
of	IN	of
AGEs	NNS	age
and	CC	and
RAGE	NNP	RAGE
signaling	NN	signaling
appears	VBZ	appear
to	TO	to
be	VB	be
a	DT	a
double-edged	JJ	double-edged
sword	NN	sword
with	IN	with
degenerative	JJ	degenerative
and	CC	and
protective	JJ	protective
effects	NNS	effect
.	.	.
</s>
<s type="decl">
This	DT	this
also	RB	also
appears	VBZ	appear
to	TO	to
be	VB	be
true	JJ	true
in	IN	in
respect	NN	respect
to	IN	to
the	DT	the
role	NN	role
of	IN	of
Wnt	NNP	Wnt
signaling	NN	signaling
in	IN	in
aging	NN	aging
.	.	.
</s>
</p>
<p>
<s type="decl">
The	DT	the
canonical	JJ	canonical
Wnt/β-catenin	NN	Wnt/β-catenin
signaling	NN	signaling
cascade	NN	cascade
acts	VBZ	act
as	IN	as
a	DT	a
pivotal	JJ	pivotal
regulator	NN	regulator
of	IN	of
developmental	JJ	developmental
and	CC	and
pathogenesis	NN	pathogenesis
pathways	NNS	pathway
including	VBG	include
cell	NN	cell
stemness	NN	stemness
maintenance/differentiation	NN	maintenance/differentiation
,	,	,
carcinogenesis	NN	carcinogenesis
,	,	,
and	CC	and
aging-related	JJ	aging-related
phenotypes	NNS	phenotype
.	.	.
</s>
<s type="decl">
Moreover	RB	moreover
,	,	,
there	EX	there
is	VBZ	be
clear	JJ	clear
evidence	NN	evidence
for	IN	for
a	DT	a
role	NN	role
of	IN	of
the	DT	the
Wnt	NNP	Wnt
pathway	NN	pathway
in	IN	in
mitochondrial	JJ	mitochondrial
respiratory	JJ	respiratory
capacity	NN	capacity
and	CC	and
metabolic	JJ	metabolic
homeostasis	NN	homeostasis
,	,	,
especially	RB	especially
of	IN	of
glucose	NN	glucose
metabolism	NN	metabolism
.	.	.
</s>
<s type="decl">
Within	IN	within
the	DT	the
canonical	JJ	canonical
Wnt	NNP	Wnt
signaling	NN	signaling
pathway	NN	pathway
,	,	,
β-catenin	NN	β-catenin
is	VBZ	be
the	DT	the
central	JJ	central
player	NN	player
.	.	.
</s>
<s type="decl">
Normally	RB	normally
,	,	,
excess	JJ	excess
β-catenin	NN	β-catenin
is	VBZ	be
rapidly	RB	rapidly
degraded	VBN	degrade
by	IN	by
the	DT	the
ubiquitin-proteasome	JJ	ubiquitin-proteasome
pathway	NN	pathway
.	.	.
</s>
<s type="decl">
Activation	NN	Activation
of	IN	of
the	DT	the
pathway	NN	pathway
leads	VBZ	lead
to	IN	to
the	DT	the
stabilization	NN	stabilization
of	IN	of
β-catenin	NN	β-catenin
and	CC	and
its	PRP$	its
accumulation	NN	accumulation
within	IN	within
the	DT	the
cytosol	NN	cytosol
and	CC	and
the	DT	the
nucleus	NN	nucleus
,	,	,
where	WRB	where
it	PRP	it
interacts	VBZ	interact
with	IN	with
T-cell	NN	t-cell
factor/lymphoid	NN	factor/lymphoid
enhancer-binding	NN	enhancer-binding
factor	NN	factor
(	-LRB-	(
TCF/LEF	NNP	TCF/LEF
)	-RRB-	)
transcription	NN	transcription
factors	NNS	factor
and	CC	and
thereby	RB	thereby
regulates	VBZ	regulate
transcription	NN	transcription
of	IN	of
multiple	JJ	multiple
target	NN	target
genes	NNS	gene
.	.	.
</s>
<s type="decl">
During	IN	during
recent	JJ	recent
years	NNS	year
,	,	,
a	DT	a
multitude	NN	multitude
of	IN	of
other	JJ	other
crosstalks	NNS	crosstalk
and	CC	and
co-operations	NNS	co-operation
affecting	VBG	affect
the	DT	the
pathway	NN	pathway
have	VBP	have
been	VBN	be
identified	VBN	identify
.	.	.
</s>
<s type="decl">
Interestingly	RB	interestingly
,	,	,
variants	NNS	variant
of	IN	of
the	DT	the
TCF-4	NNP	TCF-4
(	-LRB-	(
TCF7L2	NNP	TCF7L2
)	-RRB-	)
gene	NN	gene
have	VBP	have
been	VBN	be
associated	VBN	associate
with	IN	with
increased	VBN	increase
risk	NN	risk
of	IN	of
type	NN	type
2	CD	2
diabetes	NNS	diabet
.	.	.
</s>
</p>
<p>
<s type="decl">
Based	VBN	base
on	IN	on
that	DT	that
knowledge	NN	knowledge
,	,	,
we	PRP	we
hypothesized	VBD	hypothesize
that	IN	that
Wnt	NNP	Wnt
ligands	NNS	ligand
as	IN	as
secreted	VBN	secrete
,	,	,
cysteine-rich	JJ	cysteine-rich
proteins	NNS	protein
are	VBP	be
susceptible	JJ	susceptible
to	IN	to
α-DC-mediated	VBN	j-DC-mediate
modifications	NNS	modification
and	CC	and
that	IN	that
glycation	NN	glycation
might	MD	might
modulate	VB	modulate
their	PRP$	their
signaling	NN	signaling
activities	NNS	activity
.	.	.
</s>
<s type="decl">
For	IN	for
this	DT	this
study	NN	study
,	,	,
we	PRP	we
decided	VBD	decide
to	TO	to
use	VB	use
Wnt3a	NNP	Wnt3a
as	IN	as
a	DT	a
proof	NN	proof
of	IN	of
principle	NN	principle
to	TO	to
study	VB	study
effects	NNS	effect
of	IN	of
GO-treatment	NNP	GO-treatment
on	IN	on
Wnt3a	NNP	Wnt3a
conditioned	VBN	condition
medium	NN	medium
(	-LRB-	(
Wnt3a	NNP	Wnt3a
CM	NNP	CM
)	-RRB-	)
.	.	.
</s>
<s type="decl">
We	PRP	we
observed	VBD	observe
that	IN	that
the	DT	the
ratio	NN	ratio
of	IN	of
phospho-β-catenin	NN	phospho-β-catenin
to	IN	to
total	JJ	total
β-catenin	NN	β-catenin
increased	VBD	increase
.	.	.
</s>
<s type="decl">
As	IN	as
a	DT	a
further	JJR	further
consequence	NN	consequence
,	,	,
Wnt3a-induced	JJ	Wnt3a-induced
activation	NN	activation
of	IN	of
the	DT	the
β-catenin/TCF	NNP	β-catenin/TCF
transcription	NN	transcription
complex	NN	complex
was	VBD	be
reduced	VBN	reduce
as	IN	as
shown	VBN	show
by	IN	by
reporter	NN	reporter
gene	NN	gene
assays	NNS	assay
and	CC	and
by	IN	by
decreased	VBN	decrease
expression	NN	expression
of	IN	of
endogenous	JJ	endogenous
Wnt	NNP	Wnt
target	NN	target
genes	NNS	gene
.	.	.
</s>
</p>
</text>